Evidence map›Paper›PMID 37650931›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

CT-guided percutaneous marking of small pulmonary nodules with [

Nikola Doncic, Christoph J Zech, Damian Wild, Helga Bachmann, Makhmudbek Mallaev, Nikolay Tsvetkov, Aljaz Hojski, Martin T L Takes, Didier Lardinois

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nikola DoncicDepartment of Thoracic Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.ORCID 0000-0002-3669-8055
Christoph J ZechDepartment of Radiology and Nuclear Medicine, Division of Interventional Radiology, University Hospital Basel, Basel, Switzerland.
Damian WildDepartment of Radiology and Nuclear Medicine, Division of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-8135-5350
Helga BachmannDepartment of Thoracic Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Makhmudbek MallaevDepartment of Thoracic Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Nikolay TsvetkovDepartment of Thoracic Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Aljaz HojskiDepartment of Thoracic Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Martin T L TakesDepartment of Radiology and Nuclear Medicine, Division of Interventional Radiology, University Hospital Basel, Basel, Switzerland.
Didier LardinoisDepartment of Thoracic Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. didier.lardinois@usb.ch.
University Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe detection of small lung nodules in thoracoscopic procedure is difficult when the lesions are not located within the outer border of the lung. In the case of ground-glass opacities, it is often impossible to palpate the lesion. Marking lung nodules using a radiotracer is a known technique. We analysed the accuracy and safety of the technique and the potential benefits of operating in a hybrid operating room.

methods57 patients, including 33 (58%) females with a median age of 67 years (range 21-82) were included. In 27 patients, we marked and resected the lesion in a hybrid room. In 30 patients, the lesion was marked at the department of radiology the day before resection. [

resultsPrecise detection and resection of the nodules was possible in 95% of the lesions and in 93% of the patients. Complete thoracoscopic resection was possible in 90% of the patients. Total conversion rate was 10%, but conversion due to failure of the marking of the nodule was observed in only 5% of the patients. Histology revealed 28 (37%) primary lung cancers, 24 (32%) metastases and 21 (28%) benign lesions. In 13 (23%) patients, minor complications were observed. None of them required additional interventions.

conclusionThe radio-guided detection of small pulmonary nodules is very accurate and safe after CT-guided injection of [

Indexed as

Lung NeoplasmsTomography, X-Ray ComputedAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedMinimally Invasive Surgical ProceduresMultiple Pulmonary NodulesOrganotechnetium CompoundsOrgan Sparing TreatmentsQuality ControlRadiopharmaceuticalsSolitary Pulmonary NoduleOrganotechnetium CompoundsRadiopharmaceuticalsTechnetium Tc 99m Aggregated Albumin[99mTc]Tc-MacrosalbCT guided percutaneous markingPulmonary nodulesRadio-guided surgeryVideo-assisted thoracoscopic surgery

Identifiers

PMID37650931
PMCPMC11300552
OpenAlexW4386305125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.